Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Sandoz Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (682)
Cancellation by sponsor (321)
Prescription medicine registration (54)
Section 14, TGO91 consent (17)
Cancellation or suspension (8)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)

Date

2024 (82)
2023 (78)
2022 (67)
2021 (121)
2020 (153)
2019 (53)
2018 (60)
2017 (50)
2016 (4)
2015 (39)
2014 (20)
2013 (24)
2012 (13)
2011 (51)
2010 (47)
2009 (37)
2008 (27)
2007 (21)
2006 (21)
2005 (54)
2004 (12)
2003 (10)
2002 (10)
2001 (6)
2000 (5)
1999 (5)
1998 (9)
1997 (4)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

1087 result(s) found, displaying 371 to 380

SORAFENIB SANDOZ (Sandoz Pty Ltd)

30 July 2021

Prescription medicine registration

Active ingredients: sorafenib tosilate.
ENALAPRIL AN enalapril maleate 20mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 July 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
ENALAPRIL AN enalapril maleate 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 July 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
ENALAPRIL AN enalapril maleate 5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 July 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
MIRTAZAPINE GH mirtazapine 45mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
ZILAREX cetirizine hydrochloride 10mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

10 June 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
ROXITHROMYCIN AN roxithromycin 150mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

17 May 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
OXYCODONE HX oxycodone hydrochloride 5 mg modified release tablet bottle Cancelled under Section 30(1)(c) of the Act

17 May 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
OXYCODONE HX oxycodone hydrochloride 80 mg modified release tablet bottle Cancelled under Section 30(1)(c) of the Act

17 May 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
OXYCODONE HX oxycodone hydrochloride 40 mg modified release tablet bottle Cancelled under Section 30(1)(c) of the Act

17 May 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd

Pages

First page
Previous page
…
Page 34
Page 35
Page 36
Page 37
Current page 38
Page 39
Page 40
Page 41
Page 42
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.